CoChat

The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B

Open access
Quinn, L P, Crook, B, Hows, M E, Vidgeon‐Hart, M, Chapman, H, Upton, N, Medhurst, A D, Virley, D J · 2008 · British Journal of Pharmacology
Cited by 118

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background and purpose: The peroxisome proliferator‐activated receptor‐γ (PPARγ) agonist pioglitazone has previously been shown to attenuate dopaminergic cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of Parkinson's disease, an effect attributed to its anti‐inflammatory properties. In the present investigation, we provide evidence that pioglitazone is effective in the MPTP mouse model, not via an anti‐inflammatory action, but through inhibition of MAO‐B, the enzyme required to biotransform MPTP to its active neurotoxic metabolite 1‐methyl‐4‐phenylpyridinium (MPP+). Experimental approach: Mice were treated with pioglitazone (20 mg kg−1 b.i.d. (twice a day), p.o., for 7 days), prior and post or post‐MPTP (30 mg kg−1 s.c.) treatment. Mice were then assessed for motor impairments on a beam‐walking apparatus and for reductions in TH immunoreactivity in the substantia nigra and depletions in striatal dopamine. The effects of pioglitazone on striatal MPP+ levels and MAO‐B activity were also assessed. Key results: Mice treated with MPTP showed deficits in motor performance, marked depletions in striatal dopamine levels and a concomitant reduction in TH immunoreactivity in the substantia nigra. Pretreatment with pioglitazone completely prevented these effects of MPTP. However, pretreatment with pioglitazone also significantly inhibited the MPTP‐induced production of striatal MPP+ and the activity of MAO‐B in the striatum. Conclusions and implications: The neuroprotection observed with pioglitazone pretreatment in the MPTP mouse model was due to the blockade of the conversion of MPTP to its active toxic metabolite MPP+, via inhibition of MAO‐B.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjp.2008.78

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 118

Metadata

Authors
Quinn, L. P., Crook, B., Hows, M. E., Vidgeon‐Hart, M., Chapman, H., Upton, N., Medhurst, A. D., & Virley, D. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-05
Volume
154
Issue
1
Pages
226-233
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2062289070
Cited by
118
References
9
FWCI
5.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.